Levels of HSP70 and AR-FL are significantly upregulated in metastatic castration-resistant prostate cancer (mCRPC) patients compared to benign prostate and primary prostate cancer in four independent GEO databases (Fig. 7a). This evidence concerns the gene AR and Familial prostate cancer.